Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study

被引:2
|
作者
Mattioli, F. [1 ]
Siri, G. [2 ]
Castelli, F. [1 ]
Puntoni, M. [2 ]
Zuccoli, M. L. [1 ]
Stimamiglio, A. [3 ]
Martelli, A. [1 ]
机构
[1] Univ Genoa, Dept Internal Med, Clin Pharmacol & Toxicol Unit, Genoa, Italy
[2] EO Galliera, Sci Directorate, Clin Trial Unit, Genoa, Italy
[3] Local Hlth Author ASL3 Genovese, Italian Natl Hlth Syst, Genoa, Italy
来源
PATIENT PREFERENCE AND ADHERENCE | 2017年 / 11卷
关键词
generic drug; population-based survey; generic substitution; opinion; experience; MEDICINES; PERCEPTIONS;
D O I
10.2147/PPA.S126486
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Generic drugs use in the Liguria region is higher than the Italian average, but lower than in other European countries. No data exist about real-life prescription and level of awareness of generic drugs. In this study, we analyzed demographic, social, economic and cultural factors that may affect the level of awareness of generic drugs and their effective use. Methods: We conducted a population survey using a structured questionnaire, administered to a sample of 8 outpatient clinics of general practitioners located in different districts of Genoa (Liguria, Italy). Multivariate logistic modeling was adopted to study the relationship between awareness/use of generic drugs and characteristics of subjects. Results: Out of 2,000 outpatients surveyed, 95% were aware of generic drugs: these were mostly females (OR = 2.2, 95% CI: 1.4-3.6),>35 years old (OR.6.0 vs 18-35 years), with a high level of education (OR.4.4 vs "elementary sch"), living in the west side of the city (OR = 1.9 vs center); of these, only 59% declared that they effectively use generic drugs. Users were younger (OR = 3.1, 18-35 years vs.65 years), with a high level of education (high school/university degree vs no title/elementary/secondary school OR = 1.7), and were aware of the lower cost compared with branded drugs, and were mainly informed by pharmacists and physicians. Conclusions: Although subjects were substantially aware of the existence of generic drugs, similar to 40% still did not use them; doubts about their efficacy seem to be mainly driven by the idea that cheaper drugs lead to lower product quality, in terms of efficacy, safety and tolerability. New education policies on generic drugs are needed.
引用
收藏
页码:1423 / 1433
页数:11
相关论文
共 50 条
  • [31] Real-world data in drug development strategies for orphan drugs: Tafasitamab in B-cell lymphoma, a case study for an approval based on a single-arm combination trial
    Serrano, Philippe
    Yuen, Hiu Wah
    Akdemir, Julia
    Hartmann, Markus
    Reinholz, Tatjana
    Peltier, Sylvie
    Ligensa, Tanja
    Seiller, Claudia
    Bourhis, Achta Paraiso Le
    DRUG DISCOVERY TODAY, 2022, 27 (06) : 1706 - 1715
  • [32] Misconceptions of Spanish general practitioners' attitudes toward the management of urinary tract infections and asymptomatic bacteriuria: an internet-based questionnaire study
    Llor, Carles
    Moragas, Ana
    Hernandez, Silvia
    Crispi, Silvia
    Cots, Josep M.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2017, 30 (05) : 372 - 376
  • [33] Post-marketing safety assessment of constipation drugs: a real-world pharmacovigilance study based on FAERS database
    Zhang, Wenyu
    Wang, Hui
    Yang, Shiwei
    Pang, Xue
    Hu, Wenqi
    Zhang, Guang
    Xin, Xuezhi
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [34] Real-World Inpatient Use of Oral Antidiabetes Drugs: A Multicenter, Retrospective, Hospital-Based Cohort Study
    Pasquel, Francisco J.
    Magee, Michelle F.
    Hochberg, Irit
    Fortin, Charlie
    Migdal, Alexandra
    Cardona, Saumeth
    Fayfman, Maya
    Guo, Yi
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES, 2020, 69
  • [35] Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group (KCSG).
    Han, Hye Sook
    Lee, Kyoung Eun
    Suh, Young Ju
    Jee, Hee-Jung
    Kim, Bum Jun
    Kim, Hyeong Su
    Lee, Keun-Wook
    Ryu, Min-Hee
    Baek, Sun Kyung
    Park, In Hae
    Ahn, Hee Kyung
    Jeong, Jae Ho
    Kim, Min Hwan
    Byun, Ji-Hye
    Kim, Dong Sook
    An, Hyonggin
    Park, Yeon Hee
    Zang, Dae Young
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18759 - E18759
  • [36] Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system
    Wang, Hongli
    Zhong, Guizun
    Ji, Huanhuan
    Chen, Siqi
    Xie, Qinqin
    Shen, Zhengze
    Jia, Yuntao
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [37] Real-world cost effectiveness of first-line pembrolizumab for advanced melanoma: A population-based study by the Canadian Real-world Evidence Value for Cancer Drugs (CanREValue) Collaboration.
    Hanna, Timothy
    Aktar, Suriya
    Arciero, Vanessa
    Liu, Ning
    Chan, Kelvin K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 17 - 17
  • [38] Bleeding risk after acupuncture in patients taking anticoagulant drugs: A case control study based on real-world data
    Hsieh, Hsu-Tung
    Chou, Hui-Jer
    Wu, Pei-Yun
    Lin, Shun-Ku
    COMPLEMENTARY THERAPIES IN MEDICINE, 2023, 74
  • [39] Generic dispensing rates for substitutable drugs prescribed by general practitioners compared with other private ambulatory specialists: A study based on a French national reimbursement database
    Figoni, Hugo
    Robert, Sarah
    Bonello, Kim
    Ibanez, Gladys
    Chastang, Julie
    Estellat, Candice
    EUROPEAN JOURNAL OF GENERAL PRACTICE, 2024, 30 (01)
  • [40] Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study
    Lin, Jia-Ling
    Chen, Po-Sheng
    Lin, Hui -Wen
    Tsai, Liang-Miin
    Lin, Sheng-Hsiang
    Li, Yi-Heng
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (08) : 1213 - 1225